Natural killer cells in clinical development as non-engineered, engineered, and combination therapies

Natural killer (NK) cells are unique immune effectors able to kill cancer cells by direct recognition of surface ligands, without prior sensitization. Allogeneic NK transfer is a highly valuable treatment option for cancer and has recently emerged with hundreds of clinical trials paving the way to f...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamers-Kok, Nina, Panella, Denise, Georgoudaki, Anna-Maria, Liu, Haiping, Özkazanc, Didem, Kučerová, Lucia, Duru, Adil Doganay, Spanholtz, Jan, Raimo, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644572/
https://www.ncbi.nlm.nih.gov/pubmed/36348457
http://dx.doi.org/10.1186/s13045-022-01382-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644572/
https://www.ncbi.nlm.nih.gov/pubmed/36348457
http://dx.doi.org/10.1186/s13045-022-01382-5

Ejemplares similares